Bristol Myers CEO says India to have largest R&D presence outside US by 2025

U.S. drugmaker Bristol Myers Squibb (BMY.N) aims to expand its research and development presence in India and expects its newly inaugurated Hyderabad facility to become its largest unit outside the U.S. by 2025, CEO Christopher Boerner said on Tuesday.